MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Characterising Natural Killer cells in early Parkinson’s disease

    J. Holbrook, B. Patel, M. Camacho, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To determine whether the number and phenotype of Natural Killer (NK) cells in the blood is altered in early Parkinson’s disease (PD). Background: Accumulating…
  • 2022 International Congress

    Lymphocyte count/neutrophil-to-lymphocyte ratio and mild cognitive impairment in Parkinson’s disease

    E. Contaldi, L. Magistrelli, S. Gallo, C. Comi (Novara, Italy)

    Objective: The present study aimed to elucidate whether i) lymphocyte count and neutrophil-to-lymphocyte ratio (NLR) can discriminate Parkinson's disease (PD) patients from healthy controls (HC);…
  • 2022 International Congress

    Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: the PD COMM randomised controlled trial.

    C. Sackley, C. Rick, S. Patel, R. Woolley, M. Brady, A. Nicoll, S. Dickson, G. Beaton, C. Smith, H. Nankervis, C. Burton, P. Masterson-Algar, N. Ives, S. Jowett, Z. Abdali, L. Sharp, T. Jeffreys, C. Clarke (London, United Kingdom)

    Objective: To evaluate the clinical effectiveness of two speech and language therapy (SLT) approaches compared to no SLT (control) for people with Parkinson’s disease (PD).…
  • 2022 International Congress

    A Novel Mutation of GCH1 Gene in a Case of Dopa-responsive Dystonia with Oculogyric Crises

    T. Kim, D. Yoo, TB. Ahn (Seoul, Republic of Korea)

    Objective: To report a patient with a novel mutation of GCH1 gene presenting as dopa-responsive dystonia (DRD), parkinsonism, and oculogyric crises (OGC) Background: Autosomal dominant…
  • 2022 International Congress

    A bitter syndrome as a cause of refractory movement disorders

    DD. García-Meléndez, F. Muñoz Escudero, MI. Morales-Casado, P. Lobato Casado, AM. Diezma Martín, G. Tabar Comellas, N. Sánchez Cano, B. Canovas Gaillemin, N. López Ariztegui (Toledo, Spain)

    Objective: Submit a case of GLUT-1 deficiency for consideration in the differential diagnosis of movement disorders and refractory epilepsies because early treatment will prevent progressive…
  • 2022 International Congress

    Effect of exercise on brain metabolism and energetics in PD

    C. Bevington, R. Jayde Williams, B. Pike, J. Mckenzie, J. Zhang, W. Luh, AJ. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To identity the effect of exercise on brain metabolism and energetics in PD using PET/MR imaging. Background: Aerobic exercise slows PD progression as reflected…
  • 2022 International Congress

    Freezing of Gait Can Predict Cognitive Decline in Parkinson’s Disease

    Y. Qu, JT. Li, YP. Chen, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)

    Objective: To investigate the associations between cognitive impairment and cognitive decline in different domains and FOG status using multiple neuropsychological tests. Background: Freezing of gait…
  • 2022 International Congress

    Clinical Manifestations of Metabolic Syndrome in Parkinson’s Disease – Report from Indonesia Tertiary Referral Hospital

    DA. Soraya, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to determine the prevalence of metabolic syndrome and related factors in Parkinson's disease (PD). Background: Parkinson's disease is a neurodegenerative disorder,…
  • 2022 International Congress

    Evaluation of the anxiolytic effects of naringenin in rotenone-induced rat model of Parkinson’s disease by an elevated plus maze test

    S. Madiha (Karachi, Pakistan)

    Objective: The study was designed to assess the anxiolytic effects of naringenin on rotenone-induced anxiety-like behavior, biochemical and neurochemical alterations. Background: Anxiety is a preclinical…
  • 2022 International Congress

    Is left handedness associated with Parkinson’s disease? Evidence from the E3N cohort study and Mendelian randomization.

    G. Pesce, PE. Sugier, C. Domenighetti, F. Artaud, T. Truong, E. Flamand-Roze, M. Canonico, A. Elbaz (Villejuif, France)

    Objective: To investigate the association of hand preference with Parkinson’s disease (PD) (1) in a large prospective cohort study and (2) through a Mendelian randomization…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley